- $144.29bn
- $189.39bn
- $63.63bn
- 98
- 83
- 77
- 98
Pfizer Inc - Pfizer invite for Jan 22 analyst meeting
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Jean-Paul Valles Leaves Pfizer Board of Directors
AnnouncementPfizer Inc New Pfizer Data Helps to Identify
AnnouncementPfizer Inc - Pfizer to Return Indiplon Worldwide Rights to Neurocrine
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Repatriation
AnnouncementPfizer Inc - Governance
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Regulatory Approval - Product Approval
AnnouncementPfizer Inc - Pfizer Declares a 29-cent Third-Quarter, 2007, Dividend
AnnouncementPfizer Inc - Pfizer Board of Directors to Initiate Face-to-Face Meetings with Co
AnnouncementPfizer Inc - Pfizer Statement on Patent Office Communication
AnnouncementPfizer Inc Pfizer Receives Approval from Chinas Ministry of Commerce for Pendin
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc Pfizer Receives Approval From Australian Competition And Consumer Com
AnnouncementPfizer Inc - Esperion Therapeutics Completes $22.75 M Series A Financing
AnnouncementPfizer Inc - Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patie
Announcement